Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study
Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and established markers of cardiotoxicity in breast cance...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2024-01-01
|
| シリーズ: | Cardio-Oncology |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s40959-023-00191-0 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
